Firstword Pharma

1 trends tracked about this subject — the full history, oldest to newest below.

▲ Peaking Business

AstraZeneca's tozorakimab has shown strong Phase III clinical trial results by reducing chronic obstructive pulmonary disease exacerbations.

2 sources 2 articles v 1 2h ago

\n \n \n

\n \n \n \n